Differences between the effects of metoprolol and prazosin on the forearm vasculature in primary hypertension

Journal of Hypertension

Volumn 15, Issue 11, 1997, Pages 1317-1326

  Gretzer, Inger ^a   Hjemdahl, Paul ^b  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Noradrenaline; Vascular adaptation; Vasoconstriction; 1 adrenoceptor blockade; 1 adrenoceptor blockade

Indexed keywords

ANTIHYPERTENSIVE AGENT; METOPROLOL; METOPROLOL TARTRATE; NORADRENALIN; PRAZOSIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL BLOOD; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; FOREARM; FOREARM BLOOD FLOW; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REST; SYMPATHETIC TONE; THORAX PAIN; VASCULAR RESISTANCE; VASCULARIZATION; VASOCONSTRICTION; VEIN OCCLUSION PLETHYSMOGRAPHY; VENOUS BLOOD; VERTIGO;

EID: 0030712124     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715110-00017     Document Type: Article

References (36)

1. Freis ED: Hemodynamics of hypertension. Physiol Rev 1960, 40:27-54.
2. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982, 62:347-504.
3. Sievertsson R: The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand 1970, 343 (Suppl):1-56.
4. Korner PI, Angus JA, Bobik A, Jennings GL: Amplifier function of resistance vessels and the left ventricle in hypertension. J Hypertens 1991, 9 (suppl 2):S31-S41.
5. Weiss L: Long-term treatment with antihypertensive drugs in spontaneously hypertensive rats (SHR). Effects on blood pressure, survival rate and cardiovascular design. Acta Physiol Scand 1974, 91:393-408.
6. Mulvany MJ: Structure and function of small arteries in hypertension. J Hypertens 1990, 8 (suppl 7):S225-S232.
7. Safar ME, Bouthier JA, Levenson JA, Simon AC: Peripheral large arteries and the response to antihypertensive treatment. Hypertension 1983, 5 (suppl II):63-68.
8. Dahlöf B: The role of antihypertensive pharmacologie treatment in countering adverse pathophysiological profiles: influence on small arteries. Am Heart J 1987, 114:984-991.
9. Lever AF: Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986, 4:515-524.
10. Hjemdahl P, Friberg P: Biochemical assessment of sympathetic activity and prejunctional modulation of noradrenaline release in humans. J Hypertens 1996, 14:147-150.
11. Dohn K: Plethysmographs usable during functional states recording volume changes in ml per 100 ml of extremity. Rep Steno Hosp 1956, 6:147-168.
12. Graaf F, Westersten A: Untersuchungen über Eigenschaften und Verwendungsmöglichkeiten eines flexiblen Extremitätenplethysmografen. Acta Physiol Scand 1959, 46:1-18.
13. Gretzer I, Inacio J, Olsson A: Computerised evaluation of peripheral blood flow in humans during maximal vasodilatation in man using venous occlusion plethysmography. Clin Physiol 1995, 15:131-141.
14. Hjemdahl P: Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Meth Enzymol 1987, 142:521-534.
15. Hjemdahl P: Plasma catecholamines - analytical challenges and physiological limitations. Baillière's Clin Endocrinol Metab 1993, 7:307-353.
16. Ervik M: Quantitative determination of metoprolol in plasma and urine by gas chromatography. Acta Pharmacol Toxicol 1975, 36 (suppl V):136-144.
17. Twomey TM, Hobbs DC: Analysis of prazosin in plasma by a sensitive high-performance liquid chromatographic fluorescence method. J Pharm Sci 1978, 67:1468-1469.
18. Conway J: A vascular abnormality in hypertension. A study of blood flow in the forearm. Circulation 1963, 27:520-529.
19. Dahlöf B: Structural cardiovascular changes in essential hypertension. Blood Pressure 1992, 1 (suppl 6): 1-75.
20. Izzo JL, Licht MR, Smith PJ, Larrabee PS, Radke KJ, Kallay MC: Chronic effects of direct vasodilatation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension. Am J Cardiol 1987, 60:303-308.
21. Eklund B, Hjemdahl P, Seideman P: Effects of prazosin on hemodynamics and sympatho-adrenal activity in hypertensive patients. J Cardiovasc Pharmacol 1983, 5:384-391.
22. Agabiti-Rosei E, Musiesan ML, Geri A, Romanelli G, Montani G, Muiesan G: Relation between cardiac hypertrophy and forearm vascular structural changes before and during long-term antihypertensive treatment Am J Med 1988, 84 (suppl 3A): 125-128
23. Hartford M, Wendelhag I, Berglund G, Wallentin I, Ljungman S, Wikstrand J: Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988, 259:2553-2557.
24. Sivertsson R, Hansson L: Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. Clin Sci Mol Med 1976, 51: 77s-79s.
25. Corea L, Bentivoglio M, Verdecchia P, Provvidenza M, Motolese M: Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. Int J Clin Pharmacol Ther Toxicol 1984, 22:365-370.
26. Franz I-W, Tönnesmann U, Behr U, Ketelhut R: Long-term effect of antihypertensive therapy on left ventricular hypertrophy. J Hypertens 1987, 5 (suppl 5):S415-S418.
27. Wikstrand J, Trimarco B, Buzzetti G, Ricciardelli B, de Luca N, Volpe M, et al.: Increased cardiac output and lowered peripheral resistance during metoprolol treatment. Acta Med Scand 1983, 672 (Suppl): 105-110.
28. Lund-Johansen P: Hemodynamic changes at rest and during exercise in long-term prazosin therapy of essential hypertension. In Prazosin - Evaluation of a New Antihypertensive Agent. Edited by Cotton DWK. Amsterdam: Excerpta Medica; 1974:43-53.
29. Gretzer I, Dunér H, Lagerbäck B: Hemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation. J Hypertens 1985, 3 (suppl 3):S215-S217.
30. Svensson A, Gudbrandsson T, Sivertsson R, Hansson L: Hemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients. Br J Clin Pharmacol 1982, 13:259S-267S.
31. Heagerty AM, Aalkjær C, Stuart JB, Korsgaard N, Mulvany MJ: Small artery structure in hypertension dual process of remodelling and growth. Hypertension 1993, 21:391-397.
32. Heagerty AM, Bund SJ, Aalkjær C: Effects of drug treatment in human resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessels. Lancet 1988, ii:1209-1212.
33. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a β-blocker. Am J Hypertens 1995, 8:229-236.
34. Pedrinelli R, Taddei S, Spessot M, Salvetti A: Maximal post-ischaemic forearm vasodilatation in human hypertension: a re-assessment of the method. J Hypertens 1987, 5 (suppl 5):S431-S433.
35. Takeshita A, Mark AL: Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 1980, 2:610-616.
36. Ueno H, Takatla M, Oh-hashi S, Tomoda F, Yasumoto K, Iida H, et al.: Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril. J Hum Hypertens 1993, 7:125-130.